Dr. Anastasia Madenidou asks Prof. Christopher Sjöwall (Linköping, Sweden) about de novo lupus nephritis (LN) during treatment with belimumab. They discuss the process of collecting these observational data, the approval of belimumab for use in LN, and implications for clinical practice.
